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Abstract 
Objective  
The aim of this study was to investigate the feasibility of a structured patient-centred 
educational exchange to facilitate a, shared conversation about stroke prevention medications. 
Methods 
Participants (≥18 years) with a principal diagnosis of stroke or transient ischemic attack, were  
purposively sampled  from the stroke unit of a 780 bed teaching hospital in Australia and 
consented to participate in the study. A patient-centred educational exchange was conducted 
face to face at the bedside before discharge, and by telephone post-discharge. The structure of 
these sessions was adapted from academic detailing, an educational strategy, which includes, 
identifying experience, listening to the needs of the audience and tailoring messages to 
influence behaviour. To facilitate sharing of needs, three questionnaires, validated as research 
tools, were used to identify participants’ experience, perceptions and beliefs. The identified 
perceptions were used to personalise educational messages. The outcomes of the study were: 
to provide descriptions of patients’ perceptions necessities, and concerns about their 
condition and medications, provide examples of personalised responses to these, to evaluate 
acceptability by patients and determine the time taken to share the information. 
Results 
Sixteen participants completed both the bedside session (average duration 9 minutes) and 
the telephone follow-up (average duration 11 minutes). The strongest patient concern 
identified was having another stroke. Personalised responses included emphasising long term 
treatment in response to the perception that stroke will last for a short time, reinforcement of 
necessity for medications and further exploration of concerns.  
Conclusion 
The questionnaires engaged the participants, allowing them to share perceptions and beliefs, 
facilitating a patient-centred educational exchange in a timely manner.  
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Introduction  
Patients described as living independently with a chronic disease make a healthcare decision 
each time they take a dose of their medications. Healthcare workers who wish to support 
patients’ medication taking behaviour are interested in using their healthcare expertise to 
share in the decision making of patients requiring medicines. As well as deciding to take each 
dose, patient’s decisions may include agreeing the plan for medication use, organizing the 
supply, and reviewing the plan as a result of experience or concerns1. 
Pharmacists and other health professionals often “teach” patients about taking their 
medications as if the patient has no prior experience 2. This approach may be influenced by 
the perceived need to deliver information to ensure important disease education, instructions 
for medication taking and safety information is provided to the patient over a short time. 
However, this one-way delivery of information implies the decisions are made by the 
healthcare worker rather than shared with the patient. Shared decision making has been 
promoted internationally by governments and healthcare professionals as good clinical 
practice and a way to engage patients in their own healthcare. 3-5  
Patients who experience a stroke have a 39% cumulative incidence of a subsequent 
stroke,6 with a 90 day incidence of stroke of 11-15% for a minor stroke (<3 on the National 
Institutes of Health stroke scale)7, most of this occurring in the first two weeks. 8,9 To reduce 
this risk, international10,11 and Australian guidelines12 recommend secondary prevention 
including the use of medications for lowering blood pressure, lowering cholesterol and 
antithrombotic therapy. The early initiation and persistence to taking these medications is 
important to reduce the high rate of recurrence.9,13 Patients with poor medication 
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adherence14,15 or those experiencing adverse effects to medicines16 may not benefit. 
Systematic reviews of interventions to improve adherence to medications for secondary 
prevention of stroke found that only half have been successful.17-21 Authors of these reviews 
recommend future interventions need to address the complexity of adherence including 
education, cognitive change, and behavioural change. They recommend interventions to 
integrate into the health care system in a cost effective manner with staff trained in these 
techniques.  Behaviour change techniques used successfully in health promotion activities 
including motivational interviewing,22 health coaching and cognitive behavioural therapy23,24 
can take longer 22,25 to implement than is available during a busy and short admission 
(average shortest stay 4.2 days26) after a TIA or minor stroke.27 An approach is required 
which can address the complexity of adherence, cognitive change and behavioural change, 
while being brief and able to be implemented immediately after diagnosis of a TIA or minor 
stroke. 
We propose an approach based on the principles of academic detailing 28-30 which uses a 
social marketing framework, underpinned by social cognitive theory,31 trans-theoretical 
model of change,32 and diffusion of innovations theory.33 Academic detailing was developed 
for use with prescribers but has also been used with patients.34,35 Academic detailing 
principals include: identifying the experience and needs of the audience, tailoring messages 
to influence behaviour, using brief educational materials, and providing reinforcement with 
follow-up.30 Although there are overlaps with motivational interviewing where “change is 
elicited from the client and not imposed from without,”22 academic detailing differs in that 
the interaction is personalised to meet the patient’s needs while at the same time contains key 
messages (behavioural goals) which are a-priori (pre-determined) based on identified 
evidence to practice gaps. To identify and address patients’ needs and provide structure to the 
interaction, we chose to use questionnaires previously validated to identify patients’ 
perceptions of illness and medications.36-38 The results of the questionnaires have previously 
been used to tailor interventions.39  
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The use of questionnaires to identify patient needs and facilitate an exchange of 
information, within the structure of academic detailing has not been well described. This 
approach will be referred to as a patient-centred educational exchange (PC3EE), where the 
three Cs are context, conversation and commitment. To determine whether the PC3EE could 
facilitate a shared conversation as an intervention in a larger study, we conducted a feasibility 
study.40,41 The study investigated using the questionnaires to identify participants’ illness 
perceptions and medicines beliefs (necessities and concerns) and then the feasibility of 
addressing these with patient-centred responses. The study also needed to evaluate participant 
acceptability and practicality of the sessions (time taken).  
The aim of this study was to investigate the feasibility of a structured PC3EE to facilitate 
a shared conversation about stroke prevention medications at the bedside and with telephone 
follow-up. The outcomes were: 
Outcome 1. Descriptions and level of necessities and concerns (based on beliefs and 
perceptions) shared by patients about their stroke/TIA condition and medications. 
Outcome 2. Examples of patient-centred responses to the necessities and concerns.  
Outcome 3. Acceptability by stroke/TIA patients of the personalised exchange of information 
Outcome 4. The time taken to deliver the PC3EE 
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Methods 
Study design 
This study was a non-comparative, prospective study which used a purposive sample 
covering a range of patient demographics (for example: age, sex and type of stroke) of 
patients admitted with minor stroke or TIA in a PC3EE.  
Participants 
Participants recruited were admitted with a principal diagnosis of stroke or TIA to the 
Stroke Unit of a 780 bed tertiary teaching hospital in Australia. Inclusion criteria were 
patients aged 18 years or older, who managed their own medication, had a Mental Status 
Questionnaire (MSQ)42 score of 10/10, were planned to be discharged to their own home and 
were able to provide consent. Exclusion criteria were patients planned for transfer to a longer 
term rehabilitation unit, admitted from a residential care facility where a staff member was 
responsible for medication administration or unable to provide informed consent. 
Ethics approval was obtained from both the Hospital (HREC/14/QPAH/250) and the 
University ethics committee (Medical Research Ethics) (number 2014000784). Signed 
consent was provided by each of the participants. 
Intervention 
The intervention, consisted of two sessions, one which took place at the patients’ bedside 
during the admission and the second conducted over the telephone at least ten days after 
hospital discharge. Ten days were chosen as this allowed time for the participant to arrange 
an appointment with their general practitioner (GP). These sessions complimented usual care. 
Usual care included admission to a stroke specific ward, multidisciplinary care by the stroke 
team, education using the “Stroke Foundation” materials by the stroke nurse,43 medication 
counselling and provision of a discharge medication record44 by the stroke unit pharmacist 
and discharge advice provided by the medical staff. 
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The PC3EE was conducted by the educator, a clinical pharmacist (JC) with a postgraduate 
qualification in clinical pharmacy, over 20 years’ experience in the hospital and training in 
academic detailing.45 The structure of the PC3EE is shown in Box 1.  
 
Box 1. Structure of the patient centred educational exchange (PC3EE) 
Patient-Centred 
Context: The educator set the context of the session by introducing herself and by 
inviting the participant to ask a question by asking “What one thing would you most like to 
discuss about the medications you have been prescribed since your stroke/TIA?” This 
question was addressed before moving to the conversation.  
Conversation: The brief-illness perceptions questionnaire (brief-IPQ)36 the beliefs about 
medicines questionnaire-specific (BMQ-specific)37 and the Morisky-Green-Levine adherence 
questionnaire (MGL-scale)38 were administered verbally to identify perceptions about stroke, 
medications and previous medication taking behaviour.   
The participants’ responses to the questionnaires were used to personalise the 
conversation. This was supplemented by a two-sided, single page document (the detailing 
tool) containing an infographic to illustrate the role of the medications on one side and  a-
priori (predetermined) key messages on the other side.  
Commitment: Commitment to participation in the follow-up call, and medicine taking 
behaviour was made. 
Educational Exchange 
 
The four a-priori messages used in this study were “Know about your medications 
prescribed to reduce risk of stroke”, “Organise ongoing supply of your medications”, 
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“Continue to take these medications as agreed with your doctors” and “Report any new 
symptoms or concerns to your doctor”.  
Data collection 
Demographic data collected from the medical record included patient age, sex, stroke 
type, history of a previous stroke and whether they live alone. Participant perceptions, time 
taken to deliver the PC3EE, and qualitative data describing approaches and personalised 
messages were obtained from field notes recorded on the case record forms at both sessions. 
Participant feedback was obtained using a self-completed evaluation form (folded to hide 
responses) given to the participants by the educator after the bedside session. On the form the 
participants were asked to rate their agreement on a five point Likert scale to the following 
nine statements: I was satisfied with the session, The time taken for the session was too long, 
The materials given to me helped with my understanding, I didn’t learn anything new during 
the session, I felt I was listened to during the session, The discussions helped in relation to 
other information that has been provided, I would like the session to have been longer, I felt 
the pharmacist answered my questions and I would recommend this session for other people 
who have had a stroke/TIA. The form also contained two open questions: “What was the most 
useful part of the session?”, and “What changes would you suggest to improve the session?” 
Sample size  
To ensure that a range of patient demographics (for example: age, sex and type of stroke) 
likely to be admitted to the hospital was covered, it was considered that a sample size of 
between ten and twenty patients was likely to be sufficient to explore the use of the PC3EE. 
Analysis 
The questions asked by the participants during the context phase of the session were 
categorized into themes by the principal researcher (JC) and agreed upon through discussion 
and agreement by all 4 authors (JC, DR, JW and NC). The themes were not anticipated but 
rather determined when the data was analysed. 
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In the conversation phase the brief-IPQ consisted of 8 independent questions each scored 
on a scale between 0 and 10, and summarised as medians (IQR) (see table 3) and a final open 
question. Examples of the personalised messages provided to the participant answers are 
given for scores of 0 to 4 and scores 5 to 10 (Table 5).  
 The BMQ-specific contains ten statements, each scored out of 5 based on the 
participant’s level of agreement. Five of the statements reflect the participants’ beliefs in the 
necessity of their medicines and the remaining five the participants’ concerns beliefs towards 
their medicines. Higher scores (out of a total of 25 for each of the five statements) reflect 
stronger beliefs. The balance of necessity to concerns facilitated responses. All scores were 
summarised as median (IQR). Examples of personalized messages are provided for scores 
from 13 to 25 for necessities and concerns and for two of the concerns statements (Table 5). 
The MGL-scale contains four questions where answers indicating adherence were scored 
as one. These were added together to provide a high adherence score of four38 or a lower 
score of less than four. 
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Results  
Twenty participants, who were approached over a 6 month period, consented to be 
included in the study. Two participants did not complete the first session (one was transferred 
to another unit and one was discharged before completing the first session). Of the 18 
participants who completed the bedside session 16 also completed the telephone follow-up 
post-discharge (one of the participants was unable to be contacted for follow-up because the 
telephone was disconnected and the other had left the country). Further results are reported 
for the 16 participants who completed both sessions. The demographic characteristics of the 
16 who completed both sessions and the 20 who consented to the study are very similar and 
are shown in Table 1. 
During the context phase, when invited to ask a question about their medicines, eleven of the 
participants raised a question at the bedside session and six at the telephone follow-up. The 
participants’ questions have been categorised by themes including the need for medications, 
concerns about adverse effects, concerns about stopping current medications, comparisons 
between medications and requests for information (Table 2). The questions were addressed 
early in the session and referred to later if relevant to the conversation.  
Outcome 1. Descriptions and level of necessities and concerns (based on beliefs and 
perceptions) shared by patients about their stroke/TIA condition and medications. 
The item response rate for all three questionnaires ranged from 75% to 100%. Table 3 
shows results for the brief-IPQ questions along with a descriptor of each question. The 
participants’ strongest perception was their concern about having another stroke (median 
10/10 before discharge, 7/10 at follow-up). Table 4 shows the statements and results for the 
BMQ-specific. The median necessity score on the BMQ-specific was 21/25 in hospital and 
20/25 at home. The median concerns scores were 14/25 both in hospital and at home. Using 
the MGL-scale, eight participants scored less than 4/4 (4/4 shows high adherence) for at least 
one medication at the bedside interview and five participants scored less than 4/4 for at least 
one medication at telephone follow-up. 
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Outcome 2. Examples of patient-centred information responding to these necessities and 
concerns.  
Examples of patient-centred responses are shown in Table 5. Some of the responses 
enabled the messages to be personalised, for example “the plan is for you to take these 
medications long term” while other responses were approaches used in the conversation by 
the educator, for example, changing the pace of the conversation. For those participants who 
indicated extreme concern about having another stroke, the tone of the conversation changed, 
a pause in the conversation was allowed for reflection or recovery, followed by empathetic 
explanation of the role of medication in risk reduction. The balance of necessities to concerns 
scores in response the BMQ-specific facilitated reinforcement for participants with high 
necessity scores and enquiry for participants with high concerns scores. Exploration of 
individual concerns was conducted to promote further conversation (Table 5).Those worried 
about the long-term effects of medications were asked about previous experiences with 
unwanted effects of medications. Further discussion covered information about the potential 
adverse effects, what to do if they occur and the key a-priori message, “report concerns to 
your doctor”. For those participants where the results of the MGL-scale were less than 4/4 for 
adherence, there was discussion about plans for future medication use.  
At the commitment phase all 16 participants agreed to a follow-up telephone call and 
confirmed contact details. In addition seven participants agreed to discuss their 
antithrombotics, two to discuss their new medications, one to report on what he has done with 
his ceased medications, two agreed to report problems (bleeding, muscle pain) with their 
family doctor and one agreed to report on visiting their family doctor to monitor their blood 
pressure.  
Outcome 3. Acceptability and suitability of the study procedures and intervention.  
Ten of the initial eighteen participants completed feedback for the bedside PCEE session. All 
ten strongly agreed or agreed that they were satisfied with the session and would recommend 
it for others. Seven indicated that the session was an appropriate length by disagreeing that it 
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should have been longer or that it was too long. Most participants (9/10) agreed that the 
materials helped them and felt they were listened to, while 8/10 agreed the pharmacist 
answered their questions. Items the participants felt were useful were: “learning about my 
meds and why I am taking them”, “unhurried clear explanations”, “well done use of 
diagrams and explanation”. The improvements the participants suggested could be made 
were: “I would like to gain more knowledge” and “I hate the scales”.  
Outcome 4. The time taken to deliver the PCEE. 
The time taken for the bedside session was a mean (SD) of 27 (9) minutes with a range of 15 
to 45 minutes. The duration of the follow-up phone call was a mean (SD) of 23 (11) minutes 
with a range of 10 and 45 minutes. The mean (SD) number of days after participant discharge 
until the successful follow-up call was 13 (7) days with a range of 6 to 27 days. 
Refinement of study procedures 
To help the flow in conversation after using the questionnaires the educator began to 
incorporate some bridging sentences. An example is “Thank-you for sharing your views. I am 
going to think about those for a minute to help me with what we will talk about next.” During 
this time the educator could quickly determine the balance between necessity and concerns 
identified by the BMQ-specific and reflect on the conversation around all the questions. The 
artwork used on the infographics was adapted to be more directed at the general public and 
less like an illustration in a medical textbook. To increase telephone follow-up rates, we 
introduced the sharing of educator and participant mobile phone contacts. Messaging using 
the mobile phone contacts was used to arrange convenient follow-up call times. 
Discussion and conclusion  
The study successfully showed the feasibility of using the questionnaires to identify 
participants’ perceptions and beliefs, being able to personalise a response to these, being 
acceptable to the participants and conducted within a sustainable time. This study showed the 
ability to share experiences and information between the participant and the educator using 
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the PC3EE model. The PC3EE involves three phases: Context, Conversation and 
Commitment, which identified participant perceptions and generated personalised responses 
to create an educational exchange. Participants reported satisfaction with the intervention 
with overall positive feedback. 
The use of the invitation to ask a question during the context phase at the beginning of the 
session encouraged input from the participant rather than starting with the educators’ 
agenda.46,47 The participant’s question also allowed immediate discussion of a pressing issue 
which may impair further conversation unless that is addressed (see Table 2). 
The conversation phase of the PC3EE built on prior knowledge of the participant by use of 
the questionnaires rather than assuming the participant had no previous experience.48 We 
found that when the participant was unwilling or unable to answer an item, the lack of answer 
was still a good reference point for the conversation.49 The use of standardised questionnaires 
broached subjects that the educator may have chosen to avoid. For example, asking 
participants about their concern of having another stroke was confronting, however 15 of the 
16 participants provided a response in both sessions which indicated that the participants 
were ready to share this concern. Not every item in the questionnaires generated personalised 
messages, rather the conversation sometimes changed to be more empathetic or to discuss 
previous experiences of medication related problems. Although table 5 provides examples of 
responses, we did not generate a standardised script for future sessions. Some studies have 
been conducted where education can be personalised using  pre-programmed responses, for 
example in computerised education programs50 or text messages,51 this study shows that the 
questionnaires not only informed what was said but how it was said. The questionnaires 
provided enough structure for the exchange of information to be efficient (mean 27 minutes 
at bedside and 23 minutes by telephone), which is important with respect to participant 
fatigue, and for focus and sustainability of the PC3EE. This is particularly important for 
future training of healthcare workers to replicate this method. 
Limitations 
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A limitation of this study which was conducted in patients with a TIA or minor stroke 
who scored 10/10 on the MSQ is that a large proportion of stroke survivors have cognitive 
impairment early post stroke. The study did not attempt to determine the level of training 
which would be required to replicate the intervention. The educator facilitating the 
conversation with the patients in this study had prior clinical experience and was trained in 
academic detailing.45 The skills are those required by all healthcare professionals as they face 
the challenge of the elicitation of pertinent information from the patient and share 
information with the patient which is specific to their individual needs in a timely fashion in 
resource-poor care settings. The standardised questionnaires and the academic detailing 
framework used together can provide guidance and facilitate training of healthcare 
professionals to use this approach. Some feedback from participants on the acceptability of 
the study may have been missed because participant evaluation was only provided by 10 
participants. In some cases the participant’s evaluation was not obtained due to lack of 
opportunity to provide or retrieve the evaluation form due to transfer from the ward, 
discharge from the hospital and sometimes an acute impact on vision, or hand writing. It was 
reassuring that there were no refusals to providing feedback.  
Although all 16 participants committed to a follow-up call to discuss their medications, this 
feasibility study does not test whether the PC3EE is effective in improving patient’s self-
management of their own medications. A controlled trial (ACTRN12615000888561) has 
completed enrolment of participants to determine the impact of the PC3EE on patient self-
management of stroke prevention medications 52. The predicted future increase of an older 
population with multi morbidities 53 will result in many patients being prescribed long-term 
medications for chronic diseases for whom a structured but individualised patient-centred 
approach to share information, such as a PC3EE, may be helpful.  
 
In conclusion a “patient-centred educational exchange” using questionnaires to engage 
the participant in a shared conversation and guide the educator to personalise delivery of pre-
determined key messages is feasible to implement. 
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